Clinical Trials Browser

Completed × Carcinoid Tumor × Nivolumab × Clear all

NCT04197310 2025-01-31

Cabozantinib and Nivolumab for Carcinoid Tumors

Phase 2 Completed

19 enrolled 10 charts

Carcinoid Tumor, Neuroendocrine Tumors